Skip to main content
Premium Trial:

Request an Annual Quote

Correction: Jun 15, 2004

Premium

In the 6-08-04 issue of Inside Bioassays, the article “MIT’s Anne Carpenter Discusses HT Microscopy, Cellular Arrays” (see InsideBioassays, 6/8/2004) contained an error in the headline and the story. Carpenter is a postdoctoral researcher at the Whitehead Institute, not at MIT as the story stated. While David Sabatini, the professor in whose laboratory she works, is a professor both at Whitehead and MIT, Carpenter is employed through the Whitehead.

In the 6-08-04 issue of Inside Bioassays, the article, “Now on Its Own, Pharmacopeia Drug Discovery to “Ramp up” Internal Efforts” (see InsideBioassays, 6/8/2004) contains a factual error. The article, based on incomplete facts provided, stated that the company has a cash burn of $46 million. In fact, PDD has $46 million in cash and its expected burn is less than $5 million, according to the company.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.